152 related articles for article (PubMed ID: 20472098)
1. Atorvastatin affects TLR4 clustering via lipid raft modulation.
Chansrichavala P; Chantharaksri U; Sritara P; Ngaosuwankul N; Chaiyaroj SC
Int Immunopharmacol; 2010 Aug; 10(8):892-9. PubMed ID: 20472098
[TBL] [Abstract][Full Text] [Related]
2. Biphasic effects of atorvastatin on inflammation.
Garjani A; Andalib S; Ziaee M; Maleki-Dizaji N
Pak J Pharm Sci; 2008 Apr; 21(2):125-30. PubMed ID: 18390442
[TBL] [Abstract][Full Text] [Related]
3. Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages.
Fernandez-Lizarbe S; Pascual M; Gascon MS; Blanco A; Guerri C
Mol Immunol; 2008 Apr; 45(7):2007-16. PubMed ID: 18061674
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: a condition reversed by PKC activation.
Cuschieri J; Billigren J; Maier RV
J Leukoc Biol; 2006 Dec; 80(6):1289-97. PubMed ID: 16959900
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells.
Yang SS; Li R; Qu X; Fang W; Quan Z
Cell Immunol; 2012 Sep; 279(1):96-102. PubMed ID: 23103560
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway.
Chansrichavala P; Chantharaksri U; Sritara P; Chaiyaroj SC
Asian Pac J Allergy Immunol; 2009 Mar; 27(1):49-57. PubMed ID: 19548630
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells.
Wang Y; Zhang MX; Meng X; Liu FQ; Yu GS; Zhang C; Sun T; Wang XP; Li L; Wang YY; Ding SF; Yang JM; Zhang Y
Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1743-52. PubMed ID: 21317307
[TBL] [Abstract][Full Text] [Related]
8. Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Immunobiology; 2012 May; 217(5):533-9. PubMed ID: 21899916
[TBL] [Abstract][Full Text] [Related]
9. Acute ethanol treatment modulates Toll-like receptor-4 association with lipid rafts.
Dolganiuc A; Bakis G; Kodys K; Mandrekar P; Szabo G
Alcohol Clin Exp Res; 2006 Jan; 30(1):76-85. PubMed ID: 16433734
[TBL] [Abstract][Full Text] [Related]
10. Glycyrrhizin inhibits lipopolysaccharide-induced inflammatory response by reducing TLR4 recruitment into lipid rafts in RAW264.7 cells.
Fu Y; Zhou E; Wei Z; Song X; Liu Z; Wang T; Wang W; Zhang N; Liu G; Yang Z
Biochim Biophys Acta; 2014 Jun; 1840(6):1755-64. PubMed ID: 24462946
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyethyl starch 130/0.4 exerts its anti-inflammatory effect in endotoxemic rats by inhibiting the TLR4/NF-kappaB signaling pathway.
Xie J; Lv R; Yu L; Huang W
Ann Clin Lab Sci; 2010; 40(3):240-6. PubMed ID: 20689135
[TBL] [Abstract][Full Text] [Related]
13. Conjugated linoleic acid suppresses IRF3 activation via modulation of CD14.
Dowling JK; McCoy CE; Doyle SL; BenLarbi N; Canavan M; O'Neill LA; Loscher CE
J Nutr Biochem; 2013 May; 24(5):920-8. PubMed ID: 22901688
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression.
Wang L; Zhang X; Liu L; Yang R; Cui L; Li M
Neurosci Lett; 2010 Mar; 471(3):152-6. PubMed ID: 20100543
[TBL] [Abstract][Full Text] [Related]
15. Saikosaponin a inhibits lipopolysaccharide-oxidative stress and inflammation in Human umbilical vein endothelial cells via preventing TLR4 translocation into lipid rafts.
Fu Y; Hu X; Cao Y; Zhang Z; Zhang N
Free Radic Biol Med; 2015 Dec; 89():777-85. PubMed ID: 26475038
[TBL] [Abstract][Full Text] [Related]
16. Implications of lipid raft disintegration: enhanced anti-inflammatory macrophage phenotype.
Cuschieri J
Surgery; 2004 Aug; 136(2):169-75. PubMed ID: 15300176
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages.
Powers KA; Szászi K; Khadaroo RG; Tawadros PS; Marshall JC; Kapus A; Rotstein OD
J Exp Med; 2006 Aug; 203(8):1951-61. PubMed ID: 16847070
[TBL] [Abstract][Full Text] [Related]
19. PKC-zeta is essential for endotoxin-induced macrophage activation.
Cuschieri J; Umanskiy K; Solomkin J
J Surg Res; 2004 Sep; 121(1):76-83. PubMed ID: 15313379
[TBL] [Abstract][Full Text] [Related]
20. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
